New Jersey ALS and motor neuron disease reporting law
New Jersey approved P.L.2025, c.346, requiring health care professionals to report ALS and motor neuron disease cases to the Department of Health.
New Jersey · Effective · Effective Jan 20, 2026
What it is
- What changed
- A2980, identical to S4030, became P.L.2025, c.346 and requires health care professionals who screen for, diagnose, or provide therapeutic services to patients with ALS or motor neuron disease to confidentially report known cases to the Department of Health.
- Why it matters
- A registry and reporting rule can improve visibility into ALS and motor neuron disease prevalence and service needs, while families need clear explanation of reporting, confidentiality, data sharing, and DOH implementation materials.
- Who it touches
- Family caregivers, Care providers and plans, People receiving care, Businesses and agencies that must complypeople with ALS, ALS caregivers, people with motor neuron disease, neurologists, state public-health agencies
- What it does
- Requires something of providers, companies or agencies; Plans, studies, registries or guidance
- Identifiers
- A 2980 (session 2024) · S 4030 (session 2024)
Sources
Last reviewed Jul 4, 2026. This is information, not legal advice; check the source for the current text.